Biotech

All Articles

Sanofi flunks MS research, dealing yet another strike to Denali contract

.Sanofi has actually stopped a stage 2 difficulty of Denali Therapeutics-partnered oditrasertib in s...

Turnstone lays off 60%, shocks C-suite to stretch out money

.Turnstone Biologics is actually decreasing its own headcount by 60% as well as shaking up its C-sui...

Gilead loses hope on $15M MASH wager after weighing preclinical records

.In a year that has actually found an approval and also a range of readouts for metabolic dysfunctio...

Texas biotech axes cancer cells deal, pins wishes on being overweight

.Alaunos Therapies is axing a deal with Precigen, losing hope licensing liberties to a tailored T-ce...

Capricor allotments even more data for DMD treatment after initiating BLA

.Capricor Rehabs is taking a triumph lap for their period 2 Duchenne muscle dystrophy (DMD) trial. A...

FDA locations Kezar lupus trial in hold observing 4 individual fatalities

.The FDA has actually positioned Kezar Life Sciences' lupus trial on grip after the biotech hailed 4...

Phase 3 Scholar Stone test attacks SMA goal, delivering stockpile 200%

.A stage 3 test of Intellectual Rock's spine muscle atrophy (SMA) candidate has reached its major en...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapeutics has marked out think about a $67 thousand IPO, along with inflammati...

Galecto purchases leukemia medicine, goes down bone tissue cancer cells property in pivot

.A year after the breakdown of an idiopathic lung fibrosis candidate delivered Galecto on a search f...

Judo tosses down $100M to knock out renal condition

.Taking the mat is Judo Bio, a promising biotech equipped with $100 million to cultivate oligonucleo...